Here's Why Novacyt (EPA:ALNOV) Must Use Its Cash Wisely
Aug 15
French (CAC) Biotech Industry Analysis
UpdatedAug 15, 2024
DataAggregated Company Financials
Companies27
- 7D1.7%
- 3M-13.8%
- 1Y-26.5%
- YTD-11.0%
In the last week, the Biotech industry is up 1.7%, with Valneva up 10%. In the past year, the industry is down 27%. Earnings are forecast to grow by 14% annually.
Industry Valuation and Performance
Has the French Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 15 Aug 2024 | €3.0b | €514.7m | -€580,457,992.50 | 37x | -5.2x | 5.9x |
| Sat, 13 Jul 2024 | €3.0b | €511.7m | -€566,118,402.03 | 26.9x | -5.3x | 5.9x |
| Mon, 10 Jun 2024 | €3.4b | €509.7m | -€565,066,208.67 | 28.9x | -6x | 6.7x |
| Wed, 08 May 2024 | €3.2b | €504.3m | -€664,908,101.23 | 27.9x | -4.9x | 6.4x |
| Fri, 05 Apr 2024 | €3.2b | €502.6m | -€572,820,380.38 | 22.1x | -5.6x | 6.4x |
| Sun, 03 Mar 2024 | €3.1b | €558.7m | -€673,952,607.81 | 21.6x | -4.6x | 5.5x |
| Tue, 30 Jan 2024 | €3.2b | €594.6m | -€685,224,170.00 | 21.4x | -4.6x | 5.3x |
| Thu, 28 Dec 2023 | €3.2b | €593.8m | -€680,641,667.00 | 23.2x | -4.8x | 5.5x |
| Sat, 25 Nov 2023 | €3.2b | €594.2m | -€683,199,139.00 | 22.5x | -4.7x | 5.4x |
| Mon, 23 Oct 2023 | €3.0b | €806.6m | -€591,748,889.00 | 20.3x | -5.1x | 3.7x |
| Wed, 20 Sep 2023 | €3.7b | €812.6m | -€733,385,084.00 | 23.8x | -5.1x | 4.6x |
| Fri, 18 Aug 2023 | €3.7b | €818.2m | -€726,423,621.00 | 23.6x | -5x | 4.5x |
| Sun, 16 Jul 2023 | €3.8b | €817.1m | -€732,039,089.00 | 26.3x | -5.1x | 4.6x |
| Tue, 13 Jun 2023 | €3.7b | €820.5m | -€744,268,780.00 | 25.6x | -5x | 4.5x |
| Thu, 11 May 2023 | €3.6b | €831.4m | -€759,068,290.00 | 25.9x | -4.7x | 4.3x |
| Sat, 08 Apr 2023 | €3.5b | €946.2m | -€695,412,143.00 | 18.5x | -5x | 3.7x |
| Mon, 06 Mar 2023 | €3.6b | €1.0b | -€482,040,988.00 | 10.6x | -7.4x | 3.4x |
| Wed, 01 Feb 2023 | €3.7b | €1.0b | -€455,469,698.00 | 11.8x | -8x | 3.5x |
| Fri, 30 Dec 2022 | €3.6b | €1.0b | -€455,448,392.00 | 12.1x | -7.9x | 3.5x |
| Sun, 27 Nov 2022 | €3.5b | €1.0b | -€457,064,558.00 | 12.3x | -7.6x | 3.3x |
| Tue, 25 Oct 2022 | €3.7b | €913.5m | -€719,493,477.00 | 16.4x | -5.1x | 4x |
| Thu, 22 Sep 2022 | €3.8b | €963.0m | -€684,993,012.00 | 117x | -5.5x | 3.9x |
| Sat, 20 Aug 2022 | €4.6b | €931.0m | -€750,761,857.00 | 121.1x | -6.1x | 5x |
| Mon, 18 Jul 2022 | €4.3b | €984.5m | -€688,969,948.00 | 120.7x | -6.3x | 4.4x |
| Wed, 15 Jun 2022 | €4.1b | €989.2m | -€694,728,198.00 | 126.7x | -5.9x | 4.1x |
| Fri, 13 May 2022 | €4.3b | €1.0b | -€619,195,336.00 | 3.4x | -6.9x | 4.2x |
| Sun, 10 Apr 2022 | €5.1b | €1.1b | -€592,415,423.00 | 3.3x | -8.7x | 4.5x |
| Tue, 08 Mar 2022 | €4.4b | €947.8m | -€644,911,345.00 | 16.2x | -6.8x | 4.6x |
| Thu, 03 Feb 2022 | €5.4b | €932.5m | -€676,734,981.00 | 3x | -8x | 5.8x |
| Sat, 01 Jan 2022 | €7.1b | €929.0m | -€678,283,283.00 | 3.6x | -10.5x | 7.7x |
| Mon, 29 Nov 2021 | €7.3b | €925.7m | -€680,558,540.00 | 3.6x | -10.7x | 7.9x |
| Wed, 27 Oct 2021 | €7.2b | €929.3m | -€675,617,441.00 | 2.5x | -10.6x | 7.7x |
| Fri, 24 Sep 2021 | €7.1b | €898.2m | -€627,781,905.00 | 2.7x | -11.2x | 7.9x |
| Sun, 22 Aug 2021 | €6.4b | €899.6m | -€600,532,159.12 | 2.9x | -10.6x | 7.1x |
Price to Earnings Ratio
-10.6x
Current Industry PE
- Investors are optimistic on the French Biotechs industry, and appear confident in long term growth rates.
- The 3-year average PS ratio of 5.1x is lower than the industry's current PS ratio of 5.9x.
Past Earnings Growth
- Losses for companies in the Biotechs industry have remained mostly flat over the last three years.
- Meanwhile revenues for these companies have declined 17% per year.
- This means that the cost of doing business could be reducing since sales have declined but losses haven't fallen much further.
Industry Trends
Which industries have driven the changes within the French Healthcare industry?
| FR Market | 0.97% | |
| Healthcare | 1.12% | |
| Biotech | 1.74% | |
| Biotech | 1.74% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| VLA Valneva | €3.52 | 14.1% +€60.7m | -41.6% | PS3.2x | |
| ALNOV Novacyt | €0.79 | 49.1% +€18.3m | -17.1% | PS4.1x | |
| NANO Nanobiotix | €4.65 | 8.0% +€16.4m | -41.1% | PS6.1x | |
| ALSEN Sensorion | €0.69 | 5.5% +€10.8m | 71.1% | PS37.1x | |
| ADOC Adocia | €6.16 | 10.4% +€8.7m | -25.0% | PS15.3x |
